109 DIVISION OF HEM/ONC: ONCOLOGY BOARD REVIEW CONFERENCE "Stage IV Lung Cancer without Molecular Targets" (082522)

Dallas, TX US
August 25, 2022
Course summary
Available credit: 
  • 1.50 AMA
  • 1.50 Attendance
Course opens: 
08/25/2022
Course expires: 
08/25/2022
Event starts: 
08/25/2022 - 7:30am CDT
Event ends: 
08/25/2022 - 8:30am CDT
Cost:
$0.00
UT Southwestern Medical Center
5323 Harry Hines Blvd.
Dallas, TX 75390
United States
Course Director(s)

Amy Jones, M.D.

has no relevant financial relationships to disclose at this time.
Speaker(s)

James Kim, MD, PhD

has a financial relationship (Professional Services) with Sanofi;.
has a financial relationship (Professional Services) with COTA Inc;.

Sawsan Rashdan

has a financial relationship (Grant Or Contract) with Astrazaneca;.
has a financial relationship (Professional Services) with Astrazaneca;.

Available Credit

  • 1.50 AMA
  • 1.50 Attendance

Price

Cost:
$0.00
Please login or create an account to take this course.